Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.

Daughaday WH, Rotwein P

Endocr Rev, (1):68-91 1989

MED: 2666112

Clinical uses of insulin-like growth factor I.

Bondy CA, Underwood LE, Clemmons DR, Guler HP, Bach MA, Skarulis M

Ann Intern Med, (7):593-601 1994

MED: 8116999

Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits, and risks.

Kolaczynski JW, Caro JF

Ann Intern Med, (1):47-55 1994

MED: 8250456

Clinical review 59: Uses of human insulin-like growth factor-I in clinical conditions.

Clemmons DR, Underwood LE

J Clin Endocrinol Metab, (1):4-6 1994

MED: 8027250

Insulin-like growth factors and their binding proteins: biological actions.

Jones JI, Clemmons DR

Endocr Rev, (1):3-34 1995

MED: 7758431

The molecular mechanism of insulin action.

Kahn CR

Annu Rev Med, 429-451 1985

MED: 2986528

Title not supplied

AUTHOR UNKNOWN

Role of insulin-like growth factors in embryonic and postnatal growth.

Baker J, Liu JP, Robertson EJ, Efstratiadis A

Cell, (1):73-82 1993

MED: 8402902

Molecular and cellular aspects of the insulin-like growth factor I receptor.

LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr

Endocr Rev, (2):143-163 1995

MED: 7540132